GT Biopharma, Inc.GTBPNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank57
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P57
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | -0.08% |
| 2024 | -45.77% |
| 2023 | 41.83% |
| 2022 | 2.49% |
| 2021 | -114.90% |
| 2020 | -98.47% |
| 2019 | 65.73% |
| 2018 | -96.63% |
| 2017 | -181.35% |
| 2016 | 58.56% |